Recruiting NA Sarcoidosis

New treatment option for Sarcoidosis

Official title Comparison of the Effects of Yoga and Conventional Physiotherapy Programs in Sarcoidosis

ClinicalTrials.gov ID: NCT06848608

What this study is testing

What it's testing
Sarcoidosis is a multisystem disease, characterized by the formation of immune granulomas with various clinical symptoms depending on the involved organs, which can involve many organs and systems associated with emotional and physical consequences that affect the quality of life, whose cause is unknown, but usually affects the respiratory system, and occurs mostly in young and middle-aged adults. Lung involvement, seen in 95% of patients, causes limitation of lung capacity and decrease in inspiratory muscle strength, which are important factors that lead to an increase in dyspnea and a decrease in walking distance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 75

You may be able to join if

  • Being diagnosed with Sarcoidosis by a physician (Stage II-III-IV)
  • Pulmonary involvement
  • Having fatigue symptoms (FAS ≥22 points)
  • No immunosuppressive drug use for the last 1 year
  • No antidepressant use for the last 6 months

You likely can't join if

  • Presence of cognitive impairment that prevents communication
  • Anemia
  • Uveitis
  • Diabetes
  • Pregnancy
  • Major cardiovascular diseases
See the full eligibility criteria
Who can join
  • Being diagnosed with Sarcoidosis by a physician (Stage II-III-IV)
  • Pulmonary involvement
  • Having fatigue symptoms (FAS ≥22 points)
  • No immunosuppressive drug use for the last 1 year
  • No antidepressant use for the last 6 months
What rules you out
  • Presence of cognitive impairment that prevents communication
  • Anemia
  • Uveitis
  • Diabetes
  • Pregnancy
  • Major cardiovascular diseases
  • Fractures
  • Osteoporosis
  • Those who have a neurological or orthopedic disease that will affect the treatment
  • Those who are in the exacerbation period of the disease
  • Tumor

The study team makes the final eligibility decision.

Where it's taking place

  • Istanbul, Maltepe, Turkey (Türkiye)

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Istanbul, Maltepe, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.